|
⚲
|
| Keyboard |
| Leonard John M
✚
|
|
|---|---|
| CIK # | 0001563584 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001563584] | |
| 4 | [0001563584] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Iqvia Holdings Inc | |
| Leonard John M | |
| Intellia Therapeutics Inc | |
| Chimerix Inc | |
| Vitae Pharmaceuticals Inc | |
| AbbVie Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 156,400 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 225,400 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 34,146 | $9.21 | 314,485 |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-12-12 | Option exercise | 8,557 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-12-12 | Option exercise | 8,557 | $6.83 | 58,444 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-12-11 | Sell | 32,832 | $9.47 | 310,919 |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-12-11 | Option exercise | 49,959 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-12-11 | Sell | 49,959 | $9.49 | 474,111 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-12-11 | Sell | 5,355 | $9.59 | 51,354 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-12-11 | Option exercise | 49,959 | $6.83 | 341,220 |
|
Iqvia Holdings Inc IQV
Common Stock
|
2025-04-24 | Grant | 1,592 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-03-01 | Grant | 136,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-03-01 | Grant | 196,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-01-03 | Sell | 26,807 | $12.18 | 326,509 |
|
Intellia Therapeutics Inc NTLA
Restricted Stock Unit · derivative
|
2025-01-01 | Option exercise | 7,850 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-01-01 | Option exercise | 7,850 | ||
|
Iqvia Holdings Inc IQV
Common Stock
|
2024-05-07 | Grant | 1,047 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-03-01 | Grant | 113,586 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2024-03-01 | Grant | 163,929 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2024-01-03 | Sell | 19,223 | $29.46 | 566,310 |
| showing 20 of 197 most recent transactions | |||||